
Topic138 documents tagged
Finance Signal
Pharmaceuticals
What This Page Covers
This page collects the 138 public records POLISCOPE has tagged with “Pharmaceuticals”. Coverage spans bills, news coverage, and campaign-finance records - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Fda, and Public Health.
Active Bills
Missouri modifies pharmacy rules, raises meth precursor limits, and prohibits health plan discrimination against 340B drug entitiesSenate Bill 878 updates state laws regarding pharmaceuticals and medical devices by raising the 12-month purchase limit for certain over-the-counter meth precursors from 43.2 grams to 61.2 grams, permProposed Changes to Biosimilar Drug Review ProcessMissouri creates manufacturing tax exemptions and tax credits for critical materials and pharmaceuticalsRhode Island revises controlled substances act to remove specific opioid dosage requirements
Recent Activity
- Mon, Sep 141 item
- Wed, Sep 91 item
- Mon, Aug 311 item
- Thu, Aug 271 item
- Wed, Aug 262 items
- Vitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency riskVitruvias Therapeutics has issued a voluntary recall for Lot 504950 of its 30 mg Thyroid Tablets, USP, due to the potential for the medication to be superpotent. Patients currently using this specific
- FDA approves new pancreatic cancer treatment
- Mon, Aug 241 item
- Wed, Aug 191 item
Finance Signals
Finance-tagged records
1record associated with this topic
Reported financial relationships and timing signals. This does not prove motive or influence.
Key Actors
- 01Food and Drug Administrationorganization5 mentions
- 02Vitruvias Therapeutics, Inc.organization3 mentions
- 03504950other3 mentions
- 04Merckorganization3 mentions
- 05Donald Trumpperson3 mentions
- 06Modernaorganization2 mentions
- 07Amy Klobucharperson2 mentions
- 08Stephane Bancelperson2 mentions
- 09Department of Defenseorganization2 mentions
- 1011other2 mentions
Connections Preview
Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.
- Topic to billsMissouri modifies pharmacy rules, raises meth precursor limits, and prohibits health plan discrimination against 340B drug entities, Proposed Changes to Biosimilar Drug Review Process, Missouri creates manufacturing tax exemptions and tax credits for critical materials and pharmaceuticals (+1 more)
- Topic to peopleDonald Trump, Amy Klobuchar, Stephane Bancel
- Topic to orgsFood and Drug Administration, Vitruvias Therapeutics, Inc., Merck (+2 more)
- Topic to financeLobbying Disclosure: California Society of Health-System Pharmacists (Q2 2000)
Source Trail
Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.
- Sep 14, 2026NewsNavigator Research Poll Identifies Prescription Drug Companies and Health Insurers Among Most Corrupt Industries
- Sep 9, 2026NewsNew study links semaglutide to reduced asthma attacks and COPD flare-ups
- Aug 31, 2026NewsFlorida Attorney General investigates Pharmacy Benefit Managers for alleged monopolistic practices
- Aug 27, 2026NewsOpinion piece argues for the role of patents in pharmaceutical innovation
- Aug 26, 2026NewsFDA approves new pancreatic cancer treatment
- Aug 26, 2026NewsVitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency risk
- Aug 26, 2026NewsVitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency risk
- Aug 26, 2026NewsVitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency risk
- Aug 24, 2026NewsEmerging research suggests GLP-1 medications may assist in addiction treatment
- Aug 20, 2026State BillMissouri modifies pharmacy rules, raises meth precursor limits, and prohibits health plan discrimination against 340B drug entities
Showing 10 of 138 source records.
